Canadian Pharma Execs Face SEC Charges | Courthouse News Service
Tuesday, November 28, 2023
Courthouse News Service
Tuesday, November 28, 2023 | Back issues
Courthouse News Service Courthouse News Service

Canadian Pharma Execs Face SEC Charges

WASHINGTON (CN) - Biovail Corp., a Canadian pharmaceutical company, will pay $10 million to settle SEC charges that it juggled the books for four years "in a pattern of systemic, chronic fraud," to deceive investors and make it appear that the company was meeting earnings goals. Four executives, including the former CEO, former CFO and two current senior executives, still face charges from the SEC.

Still facing charges are former CEO Eugene Melnyk, ex-CFO Brian Crombie, Controller John Miszuk; and CFO Kenneth Howling.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...